Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Panos E. Macheras
Observed names:
P MACHERAS,
P Macheras,
P. E. MACHERAS,
P. Macheras,
P.E. Macheras,
Panayotis Macheras,
Panos Macheras,
Panos. Macheras
show all 8
Institutions:
National and Kapodistrian University of Athens,
Athena Research and Innovation Center In Information Communication & Knowledge Technologies
Observed institutions:
University of London,
State University of New York,
Johns Hopkins University,
National and Kapodistrian University of Athens,
Athena Research and Innovation Center In Information Communication & Knowledge Technologies,
University at Buffalo, State University of New York
show all 6
ORCID:
0000-0003-2375-0552
Observed ORCID:
0000-0003-2375-0552
OpenAlex ID:
A5046045274
On the use of the Weibull function for the discernment of drug release mechanisms
2005
·
Vasiliki Papadopoulou
, Kosmas Kosmidis
, et al.
·
International Journal of Pharmaceutics
·
975
A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System
2006
·
Aristides Dokoumetzidis
, Panos Macheras
·
International Journal of Pharmaceutics
·
838
A Reappraisal of Drug Release Laws Using Monte Carlo Simulations: The Prevalence of the Weibull Function
2003
·
Kosmas Kosmidis
, Panos Argyrakis
, et al.
·
Pharmaceutical Research
·
223
The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines
2019
·
Aggelos Charalabidis
, Maria Sfouni
, et al.
·
International Journal of Pharmaceutics
·
210
Quantitative Biopharmaceutics Classification System: The Central Role of Dose/Solubility Ratio
2003
·
Eleni Rinaki
, Georgia Valsami
, et al.
·
Pharmaceutical Research
·
197
Fractal kinetics in drug release from finite fractal matrices
2003
·
Kosmas Kosmidis
, Panos Argyrakis
, et al.
·
The Journal of Chemical Physics
·
179
In silico prediction of ADME and pharmacokinetics
2002
·
Alan Boobis
, Ursula Gundert-Remy
, et al.
·
European Journal of Pharmaceutical Sciences
·
178
Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches
2016
·
Panos Macheras
, Athanassios Iliadis
·
Interdisciplinary applied mathematics
·
174
Fractional kinetics in drug absorption and disposition processes
2009
·
Aristides Dokoumetzidis
, Panos Macheras
·
Journal of Pharmacokinetics and Pharmacodynamics
·
168
Quantitative Calculations in Pharmaceutical Practice and Research
1993
·
Themistoklēs P. Chatzēiōannou
, Gary D. Christian
, et al.
·
159
A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms
2013
·
Anne Zajicek
, Michael J. Fossler
, et al.
·
The AAPS Journal
·
144
PDF
Fractional kinetics in multi-compartmental systems
2010
·
Aristides Dokoumetzidis
, Richard Magin
, et al.
·
Journal of Pharmacokinetics and Pharmacodynamics
·
137
A commentary on fractionalization of multi-compartmental models
2010
·
Aristides Dokoumetzidis
, Richard Magin
, et al.
·
Journal of Pharmacokinetics and Pharmacodynamics
·
130
Unusual solubility behaviour of cyclosporin A in aqueous media
1991
·
George Ismailos
, Christos Reppas
, et al.
·
Journal of Pharmacy and Pharmacology
·
128
Modeling in Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics: Homogeneous and Heterogeneous Approaches
2006
·
Panos Macheras
, Athanassios Iliadis
·
Interdisciplinary applied mathematics
·
127
On the Heterogeneity of Drug Dissolution and Release
2000
·
Panos Macheras
, Aristides Dokoumetzidis
·
Pharmaceutical Research
·
105
The power law can describe the ‘entire’ drug release curve from HPMC-based matrix tablets: a hypothesis
2003
·
E Rinaki
, G Valsami
, et al.
·
International Journal of Pharmaceutics
·
94
The Mean Dissolution Time Depends on the Dose/Solubility Ratio
2003
·
Eleni Rinaki
, Aristides Dokoumetzidis
, et al.
·
Pharmaceutical Research
·
94
Analysis of Case II drug transport with radial and axial release from cylinders
2003
·
Kosmas Kosmidis
, Eleni Rinaki
, et al.
·
International Journal of Pharmaceutics
·
88
Identification of Biowaivers Among Class II Drugs: Theoretical Justification and Practical Examples
2004
·
Eleni Rinaki
, Aristides Dokoumetzidis
, et al.
·
Pharmaceutical Research
·
82
Gastrointestinal Drug Absorption: Is It Time to Consider Heterogeneity as Well as Homogeneity?
1997
·
Panos Macheras
, Panos Argyrakis
·
Pharmaceutical Research
·
80
On the ubiquitous presence of fractals and fractal concepts in pharmaceutical sciences: A review
2013
·
Natassa Pippa
, Aristides Dokoumetzidis
, et al.
·
International Journal of Pharmaceutics
·
75
Bioavailability and Bioequivalence: Focus on Physiological Factors and Variability
2008
·
Vangelis Karalis
, Panos Macheras
, et al.
·
Pharmaceutical Research
·
75
Drug dissolution studies in milk using the automated flow injection serial dynamic dialysis technique
1986
·
P. Macheras
, M. Koupparis
, et al.
·
International Journal of Pharmaceutics
·
73
Bioequivalence of Highly Variable Drugs: A Comparison of the Newly Proposed Regulatory Approaches by FDA and EMA
2011
·
Vangelis Karalis
, Mira Symillides
, et al.
·
Pharmaceutical Research
·
72
Show more works
View as search
Works count:
208
Citation count:
7,762
H-index:
40
I10-index:
127
Year
Topic
Type